Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate and Ezetimibe in Type IIb Dyslipidemia
NCT00349284Phase 3Completed
- Sponsor
- Solvay
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of fenofibrate, ezetimibe in familial combined hyperlipidemia (FCHL), sponsored by Solvay. Started Jan 2005; status: completed.
02
Drugs
fenofibrateezetimibe
03
Conditions
familial combined hyperlipidemia (FCHL)
Beyond the preview
Go deeper on NCT00349284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349284.